Related Experiment Video
Updated: Jun 10, 2026
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Therapeutic advances in MicroRNA targeting
Rusty L Montgomery1, Eva van Rooij
1miRagen Therapeutics, Boulder, CO 80301, USA.
Journal of Cardiovascular Pharmacology
|August 24, 2010
Summary
MicroRNAs (miRNAs) are key regulators of cellular processes and disease. Therapeutic strategies are being developed to manipulate miRNAs, particularly for cardiovascular disease treatment.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression.
- miRNAs control critical cellular functions including differentiation, growth, and survival.
- Dysregulation of miRNAs is implicated in various diseases.
Purpose of the Study:
- To review therapeutic tools for manipulating miRNA activity.
- To focus on the application of miRNA therapeutics in cardiovascular disease.
- To discuss future directions in miRNA-based therapies.
Main Methods:
- Literature review of current miRNA therapeutic strategies.
- Analysis of miRNA regulatory mechanisms.
- Focus on preclinical and clinical advancements in miRNA therapeutics.
Main Results:
- Significant progress has been made in advancing miRNA regulation into clinical applications.
- Various therapeutic tools are under investigation for miRNA manipulation.
- miRNA therapeutics show promise, especially in cardiovascular disease.
Conclusions:
- miRNA therapeutics represent a promising new class of drugs.
- Further research and development are needed to fully realize the potential of miRNA-based treatments.
- The field of miRNA therapeutics is rapidly evolving with potential for broad clinical impact.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...